| Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis J Cacicedo, I Fernandez, O Del Hoyo, A Dolado, J Gómez-Suarez, ... European journal of nuclear medicine and molecular imaging 42, 1378-1389, 2015 | 48 | 2015 |
| Hereditary pancreatic cancer: related syndromes and clinical perspective S Carrera, A Sancho, E Azkona, J Azkuna, G Lopez-Vivanco Hereditary cancer in clinical practice 15, 1-9, 2017 | 47 | 2017 |
| Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells A Buqué, JS Muhialdin, A Muñoz, B Calvo, S Carrera, U Aresti, A Sancho, ... Molecular Cancer 11, 1-15, 2012 | 45 | 2012 |
| Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies S Carrera, A Buque, E Azkona, U Aresti, B Calvo, A Sancho, M Arruti, ... Clinical and Translational Oncology 16, 339-350, 2014 | 34 | 2014 |
| Supervised physical exercise to improve the quality of life of cancer patients: the EFICANCER randomised controlled trial A Sancho, S Carrera, M Arietaleanizbeascoa, V Arce, NM Gallastegui, ... BMC cancer 15, 1-8, 2015 | 29 | 2015 |
| Oxaliplatin and capecitabine after gemcitabine failure in patients with advanced pancreatic, biliary, and gallbladder adenocarcinoma (APBC) A Sancho, G Lopez-Vivanco, ID de Corcuera, J Ferreiro, A Moreno, ... Journal of Clinical Oncology 26 (15_suppl), 15625-15625, 2008 | 19 | 2008 |
| Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC). A Munoz Llarena, J Mane, G Lopez-Vivanco, AR de Lobera, A Sancho, ... Journal of Clinical Oncology 29 (4_suppl), 304-304, 2011 | 9 | 2011 |
| Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma JM Mané, A Sancho, A Muñoz, I Rubio, R Fernández, S Carrera, N Fuente, ... Tumori Journal 96 (3), 405-410, 2010 | 8 | 2010 |
| Effectiveness of physical exercise for people with chronic diseases: The EFIKRONIK study protocol for a hybrid, clinical and implementation randomized trial MS Arietaleanizbeaskoa, A Sancho, I Olazabal, C Moreno, E Gil, ... BMC Family Practice 21, 1-11, 2020 | 7 | 2020 |
| Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): a case … S Carrera, E Beristain, A Sancho, E Iruarrizaga, P Rivero, JM Mañe, ... Hereditary Cancer in Clinical Practice 17, 1-6, 2019 | 7 | 2019 |
| Just an acute pulmonary edema? Paraneoplastic thyroid storm due to invasive mole P Jiménez-Labaig, JM Mañe, MP Rivero, L Lombardero, A Sancho, ... Case Reports in Oncology 15 (2), 566-572, 2022 | 4 | 2022 |
| Bevacizumab (B), cisplatin (C), and pemetrexed (P) plus maintenance B in chemonaive patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): A phase II study. G Lopez-Vivanco, S Carrera, A Sancho, I Marrodan, E Azcona, ... Journal of Clinical Oncology 30 (15_suppl), e18031-e18031, 2012 | 4 | 2012 |
| Nurse-supervised exercise for people with stage IV cancer: the EFICANCER randomized clinical trial N Mendizabal-Gallastegui, MS Arietaleanizbeaskoa, PM Latorre, ... Seminars in Oncology Nursing 39 (4), 151448, 2023 | 2 | 2023 |
| Gene expression profile of human colorectal cancer using oligonucleotide microarray A Munoz Llarena, A Garcia, B Suarez, M Jangi, P Garrido, J Mañe, ... Journal of Clinical Oncology 27 (15_suppl), e22182-e22182, 2009 | 2 | 2009 |
| EP1. 04-07 influence of radiotherapy in second-line treatment with immunotherapy in patients with non-small cell lung cancer E Azkona, S Carrera, I Rubio, JM Mañe, I Lacambra, A Sancho, E Novo, ... Journal of Thoracic Oncology 14 (10), S969, 2019 | 1 | 2019 |
| Thymic carcinoid tumor as single manifestation of multiple endocrine Neoplasia type 1: a clue to suspect a Germline MEN1 mutation S Carrera, I Garin, A Sancho, E Beristain, E Azkona, G López-Vivanco, ... Ann Clin Case Rep. 2017; 2 1293, 2017 | 1 | 2017 |
| Bevacizumab plus chemotherapy in the treatment of metastatic breast cancer: Hospital of Cruces experience. J Ferreiro, A Ruiz de Lobera, A Sancho, S Carrera, I Marrodan, I Rubio, ... Journal of Clinical Oncology 30 (15_suppl), e11525-e11525, 2012 | 1 | 2012 |
| Toxicity of bevacizumab (BV) in metastatic colorectal carcinoma (MCRC): Analysis in 173 consecutive patients J Ferreiro, ID de Corcuera, JM Mane, A Sancho, A Muñoz, N Fuente, ... Journal of Clinical Oncology 26 (15_suppl), 15069-15069, 2008 | 1 | 2008 |
| First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer A Gil-Negrete, JM Mane, A Ruiz de Lobera, A Martinez-Bueno, I Rubio, ... Journal of Clinical Oncology 25 (18_suppl), 16505-16505, 2007 | 1 | 2007 |
| Concurrent chemoradiotherapy (crt) with weekly docetaxel (d) for advanced head and neck cancer G López-Argumedo, G Lopez-Vivanco, R Fernandez, I Díaz de Corcuera, ... Journal of Clinical Oncology 24 (18_suppl), 15516-15516, 2006 | 1 | 2006 |
